LPLarisa V. Puzyreva

Larisa V. Puzyreva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Larisa V. Puzyreva has a total of 137 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Causes of deaths in HIV-infected patients not associated with immunodeficiency progression

    by L. V. Puzireva, M. V. Balabokhina, O. V. Antonov

    Objective: analysis of the causes of deaths in HIV-infected patients with the identification of the most significant nosology for making a prognosis and determining the direction of preventive measures. Materials and methods: the data on deaths in HIV-infected patients for the period from 2019 to 2024 living in the Omsk Region were analyzed. The study is retrospective, continuous, descriptive. The long-term dynamics were assessed and forecasting was performed using a regression model. Results: during the analyzed period, a tendency towards an increase in fatal outcomes of patients with HIV infection was noted. By gender, no significant changes in the ratio of men and women were revealed. However, significant changes in the age structure of the deceased were noted towards a shift to older age groups. The proportion of fatal outcomes from the progression of HIV infection and AIDS is decreasing, with a simultaneous increase in causes not related to the underlying disease. An increase in fatal outcomes from diseases of the cardiovascular system, gastrointestinal tract, injuries, poisoning and external causes was observed. However, when calculating the growth rate, a significant increase was noted in diseases of the respiratory system and cardiovascular pathology as causes of fatal outcomes in patients with HIV infection.   Conclusions: during the analyzed period, the age and structure of causes of fatal outcomes among patients with HIV infection changed significantly. The data obtained will allow us to develop and make informed decisions on the prevention of somatic pathology in the aging population with HIV infection.

  • Open Access

    Results of a Microbiological Study of Serogroup b Streptococcus in Patients of the Perinatal Center

    by E. V. Naumkina, L. V. Puzyreva, A. V. Dubrovskaya

    Group B Streptococcus as a commensal can cause severe infectious diseases in newborns, posing a serious danger to their lives. The aim of the study was to evaluate the frequency of registration of group B streptococcus in pregnant women, mothers and newborns Using a mini-laboratory – the analytical system «LifePad» Analyzer. Materials and methods. The study was conducted in a group of pregnant women examined at 35−37 weeks of pregnancy, intranatally in the delivery room, as well as in newborns. Microbiological data were compared with clinical manifestations of newborns. Results. Among pregnant women, S. agalactiae carriage was 4.4 %. In women examined in the delivery room, S. agalactiae was detected in 7.8 % of cases with a predominance of colonies in the vaginal contents and from the cervix. Every second pregnant woman had registration of polymicrobial associations. The use of the analytical system of the LIFEPAD analyzer in combination with reagents reduced the time for obtaining results on the presence of S. agalactiae to 60 minutes. When examining newborns, in 75.0 % of cases, streptococcus was seeded from the skin of the axilla. Generalized streptococcal infection was reported in 8.3 % of cases, localized in 16.7 % of newborns. Among the newborns of the second stage of nursing, generalized bacterial infection caused by S. agalactiae was reported in 8.0 % of cases, and localized in 40.0 %. The results of determining the sensitivity of S. agalactiae to antibacterial drugs revealed high resistance to tetracycline drugs, moderate to fluoroquinolones, macrolides and lincosamides. Some strains had a constitutive and inducible MLSb phenotype of antibiotic group resistance. Conclusion. The relatively high incidence of infectious disease manifestation in newborns at risk requires attention to the diagnosis of Group B Streptococcus carriage in pregnant women.

  • The importance of antibacterial therapy of whooping cough in children at the outpatient stage of treatment

    by L.V. Puzyreva, N.A. Sabaeva, L.N. Paimanova, E.A. Gashina, E.F. Lobova, N.V. Golovanova, E.P. Shefer

    Background. Whooping cough, a childhood infectious disease that can cause serious and potentially fatal complications, especially in very young children. The main challenge now is early diagnosis of the disease, which will ensure proper treatment and prevent transmission of infection to others. Objective. The purpose of the study was to evaluate the clinical and laboratory manifestations of whooping cough in children of different age groups, taking into account the outpatient prescription of antibacterial drugs. Materials and methods. Clinical cases of whooping cough in patients treated in a children's infectious diseases hospital (n = 114) were analyzed. Inclusion criteria: age from 0 to 17 years, characteristic clinical manifestations of whooping cough, a sample of patients treated on an outpatient basis during the first week of the disease. The average age of the patients was 3.79 ± 4.9 years. Taking into account the age criterion, the patients were divided into 3 groups. Licensed software version Statistica 13 was used. Discriminant analysis was carried out. Results. Before hospitalization in the infectious diseases hospital, the duration of cough in children was 15.4 ± 10.3 days. 63.2% sought outpatient medical care. PCR diagnostics was carried out by the local pediatric service in half of the cases. Treatment with antibacterial drugs was prescribed to 39.5% of patients. In the hospital, patients up to a year had a more severe course, with frequent complications. At the age of up to 3 years, a severe course was observed in 20.0% of patients, and in the group of patients aged 3 years and older – in 5.7% of children. A comparison of changes in the general blood test in children is provided. The results of laboratory examination of patients are described: bacteriological method, PCR diagnostics and results of enzyme immunoassay. The dependence of antibody registration on the duration of the disease in children with whooping cough has been clearly confirmed. The influence of early administration of antibacterial therapy on clinical manifestations and the development of complications in children with whooping cough was revealed. However, the laboratory diagnosis of whooping cough was not affected by outpatient treatment. Conclusion. Early diagnosis and treatment of whooping cough with antibacterial drugs before the paroxysmal stage of the disease can help mitigate the effects and reduce the spread of this highly contagious disease.

  • Open Access

    Tuberculosis of the scrotal and penile skin in an HIV-infected patient

    by L. V. Puzyreva, P. L. Gulidov, L. B. Korolev, E. A. Zablotskaya, N. I. Iovova

    Tuberculosis co-occurring with HIV infection frequently manifests as extrapulmonary localisations. The authors present a clinical case of a 53-year-old patient who initially presented with genital skin changes. The patient engaged in self-treatment, which ultimately resulted in the dissemination of the infectious process and significant alterations in the architectonics of the genital area. The patient exhibited socially withdrawn behaviour and refused medical consultation. Subsequent diagnostic evaluation revealed concomitant HIV infection. The patient succumbed to generalised tuberculosis with multiple organ involvement, including lesions in the brain, lungs, liver, spleen, large intestine, and skin. Histological examination confirmed cutaneous tuberculosis affecting the scrotum, penis, and inner surface of the thighs, characterised as the infiltrative-ulcerative form. This case highlights that timely medical intervention and overcoming psychological barriers, such as social stigma and personal embarrassment, could have saved the life of the 53-year-old patient.

  • Nipah virus: data on epidemiology, prospects for therapy and vaccine prevention

    by L. V. Puzyreva, T. E. Shvets, I. K. Kaldybaev, V. A. Shirinsky

    Since the discovery of the Nipah virus, its study has continued. Currently, three strains of it have been registered: Malaysian, Bangladeshi and Indian. Sporadic outbreaks of diseases caused by this virus have been observed among the population of South Asian countries, one of the most densely populated regions of the Earth. It is known that in the wild, bats are the reservoir of the Nipah virus, which can infect humans. At the same time, there is human-to-human transmission of the pathogen, which raises concerns about possible pandemic potential. The aim is to review the literature data on the epidemiology of infection caused by the Nipah virus. The review made it possible to characterize the epidemiological features of the territorial spread of the Nipah virus, the mechanisms and ways of its transmission, and to present the chronology of outbreak morbidity. It is determined that research is currently underway to find an etiotropic treatment and means of specific prevention.

  • The effectiveness of probiotics in viral gastroenteritis in children: a comparative open-label study

    by L.V.P Uzyreva, M.V.A Lagova, Е.F.L Obova, Е.а.GAshina Е.а.GAshina

    Objective. To evaluate the clinical efficacy and adverse effects of the complex probiotic Acipol® Forte (Lactobacillus rhamnosus GG + Bifidobacterium longum CECT 7894 + zinc citrate) compared to Linex® Forte and Enterol in children aged 5–8 years with acute intestinal infections (AII) of viral etiology. Patients and methods. An open-label, prospective, non-interventional comparative study involving 165 children randomized into 3 groups: group 1 (n = 55): Linex® Forte (Lactobacillus acidophilus LA-5 + Bifidobacterium animalis subsp. lactis BB-12); group 2 (n = 55): Enterol® (Saccharomyces boulardii CNCM I-745); group 3 (n = 55): Acipol® Forte (L. rhamnosus GG + B. longum CECT 7894 + zinc citrate). All patients received standard symptomatic and detoxification therapy. Efficacy was assessed based on primary (dynamics of diarrhea frequency, duration of diarrheal syndrome) and secondary (duration of abdominal pain, flatulence, vomiting, nausea, fever, weakness, loss of appetite) criteria. Statistical processing – nonparametric methods (Mann–Whitney criterion, χ2, Fisher's exact test). Results. Median duration of diarrhea: group 1 – 5 days, group 2 – 3 days, group 3 – 3 days (p < 0.001). By the third day of treatment, diarrhea was completely relieved in 100% of patients in groups 2 and 3, and in only 40% of patients in group 1. Pain syndrome: in group 3, it was relieved by the third day (median 3 days), in group 1 – by the seventh day, in group 2 – it was not completely relieved even by the tenth day. Flatulence: in group 3, it was relieved by day 3, in groups 1 and 2, by days 5–8. No adverse events were reported in any of the groups. Conclusion. Acipol® Forte demonstrated statistically significant superiority in terms of the speed of relief of diarrhea syndrome, elimination of abdominal pain, and flatulence compared to Linex® Forte and Enterol. The high safety and synergism of its components (LGG, B. longum, zinc citrate) justify its use as a first-line drug for viral acute intestinal infections in children, especially in the presence of pain syndrome and the risk of post-infectious functional disorders of the gastrointestinal tract. Key words: acute intestinal infections, probiotics, Lactobacillus rhamnosus GG, Bifidobacterium longum, zinc, children, diarrhea, visceral pain, microbiota, synergism

  • Clinical cases of acute flaccid paralysis in children

    by L. V. Puzyreva

    The World Health Organization recommends that all countries monitor cases of acute flaccid paralysis (AFP), which is the main clinical manifestation of paralytic poliovirus infection. This will help control poliovirus circulation and develop appropriate prevention strategies. Acute flaccid paralysis can be caused not only by viruses but also by non-infectious causes (trauma, ischemia, demyelinating diseases, etc.). The purpose — to describe clinical cases of AFP over a three-year period. Material and methods. This is a simple, retrospective, continuous, descriptive study. We analyzed cases of AFP (n = 13) among patients hospitalized in a pediatric infectious disease’s hospital from 2021 to 2024, taking into account clinical, instrumental, and laboratory data. Results. The mean age of patients was 4.8 ± 3.99 years. A seasonal pattern in the AFP cases was noted. The primary complaint was limb weakness and inability to move. In most children, neurological symptoms were preceded by fever, catarrhal changes, and exanthema. Further examination revealed a predominance of acute respiratory failure of enteroviral origin, manifested primarily by lower monoparesis. In two cases, Epstein — Barr virus infection was detected, manifesting as lower monoparesis and paraparesis. The most severe signs were those of cytomegalovirus infection, manifested as encephalomyelitis. It is not always possible to identify the etiology of acute respiratory failure, even with a comprehensive patient examination. This is due to delayed examination and a wide range of etiological factors. Conclusion. AFP is a preliminary diagnosis and is not problematic for a practicing physician. However, it requires urgent hospitalization for a comprehensive examination, differential and definitive diagnosis to ensure that no cases of polio are missed. Furthermore, appropriate and timely rehabilitation can improve functional status and quality of life, thereby reducing the incidence of disability among children.

  • Helicobacter pylori as a risk factor for atherosclerosis and cardiovascular diseases

    by L. V. Puzyryova

    Helicobacter pylori (H. pylori) is a common pathogen traditionally associated with the upper digestive tract diseases. However, recent studies have shown that it may also play a role in the development of atherosclerosis and cardiovascular diseases. Timely detection and treatment of H. pylori infection can be considered an important part of preventing cardiovascular pathology. The purpose — to evaluate the impact of Helicobacter pylori infection on the development of atherosclerosis and cardiovascular disease; to explore current ideas about its effects on lipid metabolism, the vascular wall, and systemic inflammation. Material and methods. We reviewed the 2014–2025 Russian and international studies on the association between H. pylori and atherosclerosis. Data from clinical observations and meta-analyses of infected and uninfected patients were analyzed. Results. We found a reliable association between chronic H. pylori infection and signs of clinical atherosclerosis and lipid metabolism disorders. Strains that contain the CagA gene are linked to increased inflammation and endothelial dysfunction. Eradication therapy can improve the lipid profile and reduce the level of inflammatory markers. Conclusion. Thus, H. pylori infection is a significant non-traditional risk factor for atherosclerosis and cardiovascular diseases. Timely diagnosis and treatment of infection can be considered as an additional area of prevention of cardiovascular pathology, especially in patients with dyslipidemia and metabolic syndrome.

  • Listeriosis as a cause of antenatal fetal death

    by L.V. Puzyreva, L.L. Shkabarnya, Omsk Regional Clinical Hospital, T.D. Polyakova, Omsk Region Central District Hospital, E.A. Gashina, E.F. Lobova

    Listeria (L.) monocytogenes is a Gram-positive facultative intracellular pathogen that can cause severe infections through consumption of contaminated food. The risk of developing and poor outcomes of listeriosis in pregnant women is higher than in the general population. The course and outcome of the disease are influenced not only by the host’s immune status but also by the genetic variant of L. monocytogenes and an infective dose. This article presents a brief review of the literature on listeriosis in pregnant women and a clinical case of fetal death associated with a full-blown listeriosis infection in a woman in the second trimester of pregnancy. The patient’s clinical manifestations and management are described. Symptoms of L. monocytogenes infection during pregnancy were nonspecific. Laboratory findings confirmed the infectious origin of the obstetric pathology and the severity of the infection.